|
|
Volumn 17, Issue 2, 2001, Pages 220-224
|
|
Correlation of airway obstruction and patient-reported endpoints in clinical studies
a
|
|
Author keywords
"As needed" agonist use; Asthma; Correlation; FEV1; PEF; Symptom
|
|
Indexed keywords
BECLOMETASONE;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MONTELUKAST;
PLACEBO;
STEROID;
THEOPHYLLINE;
ADOLESCENT;
ADULT;
AGED;
AIRWAY OBSTRUCTION;
ARTICLE;
ASTHMA;
CLINICAL STUDY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORRELATION FUNCTION;
DOUBLE BLIND PROCEDURE;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD;
MULTICENTER STUDY;
PEAK EXPIRATORY FLOW;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT PARAMETERS;
SCORING SYSTEM;
SELF REPORT;
SYMPTOMATOLOGY;
ACETATES;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
CLINICAL TRIALS;
CYSTEINE;
ENDPOINT DETERMINATION;
FEMALE;
FOLLOW-UP STUDIES;
FORCED EXPIRATORY VOLUME;
HUMANS;
LEUKOTRIENE ANTAGONISTS;
LEUKOTRIENES;
MALE;
MIDDLE AGED;
PEAK EXPIRATORY FLOW RATE;
PULMONARY VENTILATION;
QUINOLINES;
TREATMENT OUTCOME;
|
|
EID: 0034949689
PISSN: 09031936
EISSN: None
Source Type: Journal
DOI: 10.1183/09031936.01.17202200 Document Type: Article |
|
Times cited : (83)
|
|
References (12)
|
